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Abstract
Iron (Fe) deficiency affects an estimated 2 billion people worldwide, and
Fe supplements are a common corrective strategy. The impact of Fe deficiency
and Fe supplementation on the complex microbial community of the child gut
was studied using in vitro colonic fermentation models inoculated with immo-
bilized fecal microbiota. Chyme media (all Fe chelated by 2,2′-dipyridyl to
26.5 mg Fe L1) mimicking Fe deficiency and supplementation were continu-
ously fermented. Fermentation effluent samples were analyzed daily on the
microbial composition and metabolites by quantitative PCR, 16S rRNA gene
454-pyrosequencing, and HPLC. Low Fe conditions (1.56 mg Fe L1) signifi-
cantly decreased acetate concentrations, and subsequent Fe supplementation
(26.5 mg Fe L1) restored acetate production. High Fe following normal Fe
conditions had no impact on the gut microbiota composition and metabolic
activity. During very low Fe conditions (0.9 mg Fe L1 or Fe chelated by
2,2′-dipyridyl), a decrease in Roseburia spp./Eubacterium rectale, Clostridium
Cluster IV members and Bacteroides spp. was observed, while Lactobacillus spp.
and Enterobacteriaceae increased consistent with a decrease in butyrate (84%)
and propionate (55%). The strong dysbiosis of the gut microbiota together
with decrease in main gut microbiota metabolites observed with very low iron
conditions could weaken the barrier effect of the microbiota and negatively
impact gut health.
Introduction
Fe deficiency is one of the most common global nutri-
tional deficiencies with more than 2 billion people
affected both in industrialized and developing countries
(Zimmermann & Hurrell, 2007). Fe deficiency occurs
when body Fe requirements are not met by dietary
sources and can lead to anemia and other comorbidities.
Fe requirements are higher during growth and pregnancy,
and it is estimated that 48% of children (aged 5–14 years)
and 52% of pregnant women are anemic in developing
countries (WHO, 2001). Fe-deficiency anemia increases
risk for preterm birth and infant mortality (Zimmermann
& Hurrell, 2007) and may impair psychomotor and men-
tal development in children (Beard, 2003). Two corrective
measures recommended by the World Health Organiza-
tion are Fe fortification of foods and/or Fe supplementa-
tion. FeSO4 is a highly soluble and bioavailable form of
Fe that is widely used in Fe fortification and supplemen-
tation (Hilty et al., 2010). However, despite the high bio-
availability of FeSO4, typical fractional absorption in the
duodenum is only 5–20%, resulting in a large fraction
passing unabsorbed into the colon and being available for
the gut microbiota (Zimmermann et al., 2010).
The interest in the mammalian gut microbiota and its
implications for gut and host health has increased
tremendously during the past decade. The complex
bacterial ecosystem with a very high bacterial density pro-
vides the host with a barrier effect against the coloniza-
tion with environmental bacteria, such as pathogens
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(Stecher & Hardt, 2008). Moreover, the anaerobic metab-
olism of the bacteria in the gut makes indigestible com-
pounds such as fibers available for the host by producing
various compounds, like the short-chain fatty acids
(SCFA) acetate, propionate and butyrate, which have ben-
eficial effects on gut health. Particularly, butyrate has
been a focus of research because it can act as an energy
source for colonocytes and influences a wide array of cel-
lular functions resulting in anti-inflammatory and anti-
cancerogenic effects as well as a reduction in oxidative
stress (Hamer et al., 2008).
Dietary composition, such as fibers and micronutrient
concentrations, can affect the gut microbiota composition
and metabolic activity (Flint et al., 2007; De Vuyst &
Leroy, 2011; Metzler-Zebeli et al., 2011). The micronutri-
ent Fe is essential for most gut bacteria (Andrews et al.,
2003) except lactobacilli, which are able to grow without
Fe in a nucleotide-rich medium (Elli et al., 2000), and
thus, Fe availability in the gut may impact the dynamics
of the gut bacterial ecosystem. However, only very few
studies have investigated the effect of Fe deficiency and
Fe supplementation on the gut microbiota. Using culture
methods, infants given an Fe-fortified cow’s milk prepara-
tion had lower isolation frequencies of bifidobacteria but
higher counts of Bacteroides spp. and Escherichia coli than
children receiving an unfortified cow’s milk preparation
(Mevissen-Verhage et al., 1985a, b). Zimmermann et al.
(2010) investigated with molecular methods the gut mic-
robiota of school children supplemented with Fe for
6 months in Coˆte d’Ivoire. They found lower amounts of
lactobacilli and higher concentrations of Enterobacteria-
ceae in fecal samples of children receiving Fe-supple-
mented biscuits compared with a control group receiving
nonsupplemented biscuits. In contrast, Fe deficiency in
young women in India was associated with low levels of
lactobacilli belonging to the Lactobacillus acidophilus
group (Balamurugan et al., 2010). In a systematic review,
Fe supplementation in children was associated with a
slight but significant increased risk for diarrhea (Gera &
Sachdev, 2002). Further, it has been reported that total
anaerobes, Enterococcus spp. as well as lactobacilli were
elevated in Fe-deprived mice and that Fe supplementation
generally perturbed the gut microbiota (Tompkins et al.,
2001; Werner et al., 2011). We recently reported the
impact of Fe deficiency and subsequent Fe supplementa-
tion on the gut microbiota composition and metabolic
activity in young Sprague-Dawley rats (Dostal et al.,
2012). Fe deficiency increased Enterobacteriaceae and
Lactobacillus/Leuconostoc/Pediococcus spp., but decreased
Bacteroides spp. and Roseburia spp./Eubacterium rectale
members. Along with the bacterial composition changes,
the gut microbiota metabolites propionate and butyrate
were significantly decreased during Fe deficiency. Fe
supplementation with FeSO4 and electrolytic Fe partially
re-established the original gut microbiota composition
and led to a full recovery of metabolic activity in the rats.
In vivo studies have reported controversial results
regarding the impact of Fe on specific bacterial groups of
the gut microbiota. This may be at least in part because
of the complex interactions between the Fe concentration
in the gut lumen, the Fe status of the host, and the host
response to differing dietary Fe levels. Moreover, con-
founding factors such as dietary habits, environmental
changes, and host physiology can also impact the gut
microbiota. The use of in vitro gut fermentation models
allows investigation of the gut microbiota without effects
of the host and other environmental factors via highly
controlled parameters (Payne et al., 2012a). The in vitro
continuous colonic fermentation model developed by
Cinquin et al. using immobilized child gut microbiota
represents a good technological platform to investigate
the impact of dietary changes on the gut microbiota
(Cinquin et al., 2004, 2006; Le Blay et al., 2009; Zihler
et al., 2010; Payne et al., 2012b). This fermentation model
provides a high cell density, biodiversity, and long-term
stability because of the immobilization of the gut micro-
biota in gel beads reproducing the free cell and sessile
bacterial populations in the colon (Payne et al., 2012a).
Therefore, the aim of this study was to elucidate the
effect of Fe deficiency and dietary Fe supplementation on
the child gut microbiota composition and metabolic
activity using in vitro continuous colonic fermentation
models inoculated with immobilized fecal microbiota.
Materials and methods
Experimental setup
Three different continuous colonic in vitro fermentations
inoculated with immobilized child gut microbiota using
either single-stage reactors or a novel split-single-stage
model were carried out to test the impact of different Fe
levels, occurring during Fe deficiency and Fe supplemen-
tation, on the gut microbiota (Fig. 1a and b). All three
fermentations were aimed to mimic the conditions preva-
lent in the child proximal colon (Cinquin et al., 2006;
Le Blay et al., 2009; Zihler et al., 2010; Haug et al., 2011;
Payne et al., 2012b).
Fermentation 1 was carried out for a total of 70 days,
with two single-stage reactors inoculated with immobi-
lized gut microbiota from the same child and run in par-
allel. Reactors were continuously fed a nutritive medium
differing only in Fe concentration to mimic a standard
chyme medium, Fe deficiency, and Fe supplementation
(Fig. 1a). Moreover, infection with immobilized Salmo-
nella enterica ssp. enterica serovar Typhimurium N-15
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(Le Blay et al., 2009) was performed during ‘High Fe’
and ‘Normal Fe’ fermentation conditions (period 5, fer-
mentation 1, reactors 1 and 2) to test the establishment
and growth efficiency of the pathogen according to the Fe
content of the chyme medium during the last three fer-
mentation periods (period 5, 6, and 7, fermentation 1,
reactors 1 and 2).
During two other fermentation experiments, fermenta-
tions 2 and 3, a different reactor setup was chosen to
mimic the proximal colon of a child (Fig. 1b). A split-sin-
gle-stage continuous fermentation system with 3 reactors
was used: a first reactor inoculated with immobilized gut
microbiota was used to continuously inoculate two reac-
tors (control reactor and Fe-deficient reactor) operated in
parallel and under the conditions of the proximal colon.
Fresh ‘Normal Fe’ medium was continuously added to
the first reactor with the immobilized gut microbiota, and
effluent from this reactor containing free bacteria was
continuously transferred to the control reactor and
Fe-deficient reactor, where further medium fermentation
by the free bacteria takes place. This fermentation setup
allowed the comparison of different fermentation condi-
tions on the exact same gut microbiota. Fermentations
2 and 3 were used to confirm the effects of strong Fe defi-
ciency by continuously adding the high-affinity Fe chela-
tor 2,2′-dipyridyl to the Fe-deficient reactor. The control
reactor operated with ‘Normal Fe’ medium was used as
an indicator for stability and control.
Bacterial immobilization
Fecal samples from three healthy, 6-to-10-year-old chil-
dren, who had not received antibiotics in the previous
3 months, were collected and maintained in anaerobiosis
until bacterial immobilization in gellan–xanthan beads as
previously described (Zihler et al., 2010). Child 1 was
Dipyridyl
(a)
(b)
Fig. 1. (a) Continuous single-stage fermentation reactor with immobilized gut microbiota used for fermentation 1 and experimental setup of
fermentation 1 indicating the different medium with Fe concentrations to mimic Fe deficiency and supplementation. *Immobilized Salmonella
Typhimurium N-15 was added. (b) Continuous split-single-stage fermentation system used for fermentations 2 and 3 with a control reactor and a
Fe-deficient reactor generated by adding continuously 2,2′-dipyridyl.
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used as fecal microbiota donor for fermentation 1 and
child 2 and 3 for fermentations 2 and 3, respectively.
Fecal microbiota was immobilized under anaerobic condi-
tions in 1–2 mm gel beads composed of gellan (2.5%, w/v),
xanthan (0.25% w/v), and sodium citrate (0.2%,
w/v). Gel beads (60 mL) were immediately transferred
to a fermentation reactor (Sixfors; Infors, Bottmingen,
Switzerland) containing 140 mL of nutritive medium.
This immobilization process was carried out for each fer-
mentation experiment with a different child donor.
Salmonella Typhimurium N-15 was immobilized as
described by Zihler et al. (2010) in gellan–xanthan beads.
After overnight bead cultivation in tryptone soya broth, 2 g
of S. Typhimurium N-15 beads was added to each reactor
of fermentation 1 to mimic infection with a pathogen.
Nutritive medium design
The chyme medium composition was based on the med-
ium designed by Macfarlane et al. (Macfarlane et al., 1998)
and adapted to mimic the ileal chyme of a child as previ-
ously described (Le Blay et al., 2009). The bile salt concen-
tration was reduced to 0.05 g L1, and 0.5 mL L1
vitamin solution (Michel et al., 1998) was added after
autoclaving. The Fe concentration of the medium was con-
trolled to mimic daily Fe reaching the colon of a child dur-
ing Fe deficiency and Fe supplementation (Fig. 1a). The
iron concentration of ‘Normal Fe’ medium containing
5.0 mg L1 FeSO47H2O and 50 mg L1 hemin (Sigma-
Aldrich, Buchs, Switzerland) was 8.13 ± 1.8 mg Fe L1,
which approximates the recommended daily Fe intake of
6.3–8.9 mg for a 6–10-year-old child (WHO, 2001). For
fermentation 1, ‘Low Fe’ medium was formulated with
2.1 mg L1 FeSO47H2O and 2.3 mg L1 hemin and
contained 3.91 ± 0.1 mg Fe L1. The ‘No Fe’ medium
contained 1.56 ± 0.1 mg Fe L1, and no FeSO47H2O and
0.1 mg L1 hemin were used to mimic Fe deficiency.
Finally, media with very low Fe concentrations were
prepared by either treating the ‘No Fe’ medium with the Fe
and divalent ion chelator Chelex® 100 (sodium form;
Sigma-Aldrich) or by adding the Fe chelator 2,2′-dipyridyl
(150 or 300 lM for fermentation 1 or fermentations 2 and
3, respectively; Sigma-Aldrich). For the Chelex®-treated
medium, 12.5 g Chelex® 100 was first added to the ‘No Fe’
medium prepared without salts, stirred at 4 °C over night,
then decanted to remove the Chelex®, and finally salts were
added (KH2PO4, NaHCO3, NaCl, KCl, MgSO4, CaCl2,
MnCl2). This procedure decreased the Fe concentration in
the medium to 0.9 ± 0.2 mg Fe L1. ‘High Fe’ medium
contained 26.5 ± 2.2 mg Fe L1 (100 mg L1 FeSO47H2O
and 50 mg L1 hemin), which approximates the daily
30.4 mg Fe reaching the colon (20% absorption in duode-
num) of a 19-kg child treated with the recommended daily
Fe supplementation of 2 mg Fe kg1 body weight (CDC,
1998; WHO, 2001). All Fe concentrations of the fermenta-
tion medium were measured by atomic absorption spec-
troscopy (SpectrAA-240K with GTA-120 Graphite Tube
Atomizer Varion Techtron).
Fermentation procedures and sampling
The fermentation was carried out under the conditions of
the proximal colon according to previously described
procedures (Le Blay et al., 2009). Fecal beads were first
colonized by batch fermentation for 72 h, during which
medium replacement was performed every 12 h. During
the entire fermentation process, pH was controlled and
maintained at 5.7 by the addition of 5 M NaOH, and
temperature was kept at 37 °C. Anaerobiosis was gener-
ated by continuously flushing the headspace of all reac-
tors and medium vessels with CO2.
In the single-stage fermentation 1, the working volume
of reactors 1 and 2 (Sixfors; Infors) was set at 200 mL
with a continuous inflow of 40 mL h1 fresh medium
resulting in a mean retention time of 5 h and a total
medium inflow of 960 mL within 24 h. Different Fe
media were fed for 10 days each during seven experimen-
tal periods resulting in 70 days of continuous fermenta-
tion (Fig. 1a). At the beginning of fermentation period 5,
2 g of S. Typhimurium N-15 beads (109 CFU g1) was
added aseptically to each reactor to induce Salmonella
infection (Zihler et al., 2010).
In split-single-stage fermentations 2 and 3, beads were
first colonized for 72 h by batch fermentation, and then
the inoculum reactor was operated in continuous mode
for 6 days as described earlier (Fig. 1b). The working vol-
ume was set at 200 mL but with a high feed flow rate of
80 mL h1 fresh medium giving a short mean retention
time of 2.5 h. Control and test reactors (300 mL) were
connected in parallel to the inoculum reactor, whereas
each reactor was continuously fed with 40 mL h1 effluent
from the inoculum reactor giving a mean retention time of
7.5 h and an overall mean retention time for the split-sin-
gle-stage system of 10 h. The equipment limitations of the
split-single-stage fermentation model lead to a 2-fold
longer mean retention time than in fermentation 1, which
is within reported retention times of the child proximal
colon of 7.52 ± 5.75 h (Gutierrez et al., 2002).
Fe-deficient conditions were generated in the test reactor
by continuously adding (1.8 mL h1) 6.6 mM 2,2′-dipyridyl
solution using a membrane pump (Stepdos 03S; KNF-
flodos, Sursee, Switzerland).
During all three fermentations, daily sampling of all
reactors was performed, and samples were either frozen
at 80 °C for quantitative PCR analysis (qPCR) and
pyrosequencing or processed immediately for HPLC
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analysis. Fresh effluents were serially diluted 10-fold with
peptone water (0.1%) and plated on selective CHROM-
Agar plates (Becton Dickinson, Allschwil, Switzerland) in
duplicate for daily S. Typhimurium N-15 counts as
described previously (Zihler et al., 2010).
Genomic DNA extraction and gut microbiota
composition analysis
Total genomic DNA was extracted from 1.5 mL effluent
using the FastDNA SPIN kit for soil (MP Biomedicals,
Illkirch, France). Specific primers (Table 1) were used to
enumerate bacterial groups or species prevalent in the gut
microbiota by qPCR. qPCR was performed with an ABI
PRISM 7500-PCR sequence detection system (Applied
Biosystems, Zug, Switzerland) and using a 29 SYBR
Green PCR Master Mix (Applied Biosystems) in a 25-lL
volume as previously described (Zihler et al., 2010). Stan-
dard curves and duplicate sample analysis were performed
in each run. Standards were generated by amplifying the
16S rRNA gene of a representative bacterial strain of each
target group (Table 1). PCR amplicons of the 16S rRNA
gene for standards were purified, and DNA concentra-
tions were measured on a Nanodrop® ND-1000 Spectro-
photometer (Witec AG, Littau, Switzerland) to calculate
copy numbers per lL.
Pyrosequencing analysis
Effluent samples of the last 3 days of each fermentation
period were pooled for each reactor (total of 14 samples),
and genomic DNA was extracted with the FastDNA SPIN
kit for soil (MP Biomedicals). The extracted DNA was
sent for pyrosequencing analysis and later taxonomic
assignment of 16S rRNA gene reads to DNAVision
(Gosselies, Belgium) where the following procedures were
performed.
V5–V6 hypervariable regions of the 16S rRNA gene
were amplified with the primers 784F and 1061R
(Andersson et al., 2008), while the forward primer con-
tained the Titanium A adaptor and the reverse primer
contained the Titanium B adaptor and a barcode sequence.
PCRs were carried out in a total volume of 100 lL using
KAPA HiFi Hotstart polymerase (Kapabiosystems, Woburn,
MA), 300 nM of each primer (Eurogentec, Seraing,
Belgium), and 60 ng DNA. Amplicons were visualized on a
1% agarose gel cleaned using the Wizard SV Gel and PCR
Clean-up System (Promega, Madison, WI).
The amplicons were combined in equimolar ratios into
a single tube after the DNA concentration of each ampli-
con was determined using the Quant-iT PicoGreen
dsDNA reagent and kit (Life Technologies, Merelbeke,
Belgium). Pyrosequencing was carried out using primer A
on a 454 Life Sciences Genome Sequencer FLX instrument
(Roche Applied Science, Vilvoorde, Belgium) following
Titanium Chemistry.
The obtained sequences were assigned to samples
according to sample-specific barcodes. The pyrosequenc-
ing resulted in an average (± SD) of 12712 ± 1894
sequences per sample, and their quality was checked for
the following criteria: (1) match with barcode and prim-
ers (only one mismatch/deletion/insertion is allowed); (2)
length of at least 240 nucleotides (barcodes and primers
excluded); and (3) no more than two undetermined bases
Table 1. Primers used to enumerate specific bacterial groups by qPCR
Primer Sequence 5′–3′ Target Source
F8 AGAGTTTGATCMTGGCTC 16S rRNA gene for qPCR standard Mosoni et al. (2007)
1492R GNTACCTTGTTACGACTT
Eub 338F ACTCCTACGGGAGGCAGCAG Total bacteria Guo et al. (2008)
Eub 518R ATTACCGCGGCTGCTGG
Bac303F GAAGGTCCCCCACATTG Bacteroides spp. Ramirez-Farias et al. (2009)
Bfr-Femrev CGCKACTTGGCTGGTTCAG
F_Lacto 05 AGC AGT AGG GAA TCT TCC A Lactobacillus/Pediococcus/
Leuconostoc spp.
Furet et al. (2009)
R_Lacto 04 CGC CAC TGG TGT TCY TCC ATA TA
RrecF GCGGTRCGGCAAGTCTGA Roseburia spp./E. rectale Furet et al. (2009)
Rrec630mR CCTCCGACACTCTAGTMCGAC
Clep866mF TTAACACAATAAGTWATCCACCTGG Clostridium Cluster IV Ramirez-Farias et al. (2009)
Clep1240mR ACCTTCCTCCGTTTTGTCAAC
Fprau223F GATGGCCTCGCGTCCGATTAG Faecalibacterium prausnitzii Bartosch et al. (2005)
Fprau420R CCGAAGACCTTCTTCCTCC
xfp-fw ATCTTCGGACCBGAYGAGAC Bifidobacterium phosphoketolase Cleusix et al. (2010)
xfp-rv CGATVACGTGVACGAAGGAC
Eco1457F CATTGACGTTACCCGCAGAAGAAGC Enterobacteriaceae Bartosch et al. (2005)
Eco1652R CTCTACGAGACTCAAGCTTGC
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(denoted by N). Each sequence passing the quality check
was assigned at the family and genus level using the RDP
classifier v 2.1 (http://rdp.cme.msu.edu) (Cole et al.,
2005) with a confidence estimate cutoff at 80%.
Metabolites analysis
The concentrations of the SCFA acetate, propionate, and
butyrate, the branched-chain fatty acids isovalerate and
isobutyrate as well as the intermediate products formate
and lactate were determined in fermentation effluents by
HPLC as described previously (Cleusix et al., 2008). Mean
metabolite concentrations in effluent samples were calcu-
lated from duplicate analysis.
Statistical analysis
All statistical analysis were performed using JMP 8.0 (SAS
Institute Inc., Cary, NC). HPLC and qPCR data are
expressed as means ± SD of the last three fermentation
days of each fermentation period. qPCR data and cell
counts were log10-transformed. In fermentation 1, com-
parisons of qPCR data and SCFA concentrations were
made between two subsequent fermentation periods using
the nonparametric Kruskal–Wallis test. In fermentations
2 and 3, comparisons of SCFA concentrations were made
between control and test reactors also with the non-
parametric Kruskal–Wallis test. P values < 0.05 were
considered significant.
Results
Microbiota analysis by qPCR
The microbial composition in effluents from reactors 1
and 2 of fermentation 1 was evaluated by qPCR using
primers specific for the 16S rRNA gene of bacterial
groups (Table 2). For both reactors, total 16S rRNA gene
copy numbers remained stable over the entire fermenta-
tion and were independent of Fe concentrations in the
feed medium demonstrating the high stability of the used
in vitro fermentation system. The predominant bacterial
populations during all fermentation periods in both reac-
tors, except during period 7 of reactor 1 with very low Fe
concentrations (2,2′-dipyridyl), were Roseburia spp/E.
rectale followed by Bacteroides spp. Two different micro-
biota compositions developed in the two reactors
(Table 2, ‘Normal Fe’ reactors 1 and 2, fermentation 1)
probably due to slight changes in initial fermentation
conditions, such as pH, inoculation duration, and anaero-
biosis, which can impact the bead colonization process.
During the first six fermentation periods of reactors 1 and
2 corresponding to different Fe concentrations in the feed
medium, no major changes were observed in the 16S rRNA
gene copy numbers of Bacteroides spp., Roseburia spp./
E. rectale, Enterobacteriaceae, and Lactobacillus/Pediococcus/
Leuconostoc spp. ‘Low Fe’ and ‘No Fe’ fermentation condi-
tions significantly decreased Faecalibacterium prausnitzii
16S rRNA gene copy numbers compared with previous
‘Normal Fe’ and ‘Low Fe’ fermentation periods (Table 2).
The ‘High Fe’ fermentation condition applied after ‘No Fe’
fermentation condition significantly increased this species
along with Clostridium Cluster IV (Table 2, reactor 1).
When the Fe chelator 2,2′-dipyridyl was added to the
fermentation medium of reactor 1 to generate very low
Fe conditions, a complete reorganization of the gut mic-
robiota was observed. Whereas total 16S rRNA gene copy
numbers per mL effluent remained stable, Bacteroides
spp., Roseburia spp./E. rectale, and Clostridium Cluster IV
16S rRNA gene copy numbers decreased sharply. In con-
trast, 16S rRNA gene copy numbers of Enterobacteriaceae,
Lactobacillus/Pediococcus/Leuconostoc spp., and Bifidobacte-
rium spp. increased significantly under very low Fe condi-
tions (2,2′-dipyridyl). The treatment of the fermentation
medium with Chelex® to generate very low Fe conditions
had similar effects on the gut microbiota composition
(Table 2, reactor 2).
Microbiota analysis by pyrosequencing
The V5–V6 sequencing of the entire 16S rRNA gene pool,
sampled during the last 3 days of each fermentation per-
iod in fermentation 1, was performed by 454 FLX pyrose-
quencing (Figs 2 and 3; Supporting Information, Tables
S1–S4). After quality check, the number of sequences per
sample was reduced from 12712 ± 1894 to 9201 ± 2016
reads (Tables S1–S4). The most abundant families in both
reactors of fermentation 1 during the first six fermenta-
tion periods were Lachnospiraceae (55.4–84.4%) followed
by Ruminococcaceae (2.7–16.2%) and Bacteroidaceae
(0.2–4.5%). Correlating with the sequence annotation on
family level, Roseburia spp. and Dorea spp. (Lachnospira-
ceae), Ruminococcus spp. (Ruminococcaceae), and Bactero-
ides spp. (Bacteroidaceae) were the most annotated genera
(Figs 2 and 3).
As already observed with qPCR analysis, during the
first six fermentation periods in both reactors, Fe avail-
ability did not impact Bacteroidaceae or Lachnospiraceae
on family level. However, Ruminococcaceae were decreased
from 5.47% (‘No Fe’ period) to 2.22% during ‘High Fe’
fermentation period. Blautia spp (Lachnospiraceae) were
reduced approximately 50% during ‘No Fe’ period com-
pared with ‘Normal Fe’ or ‘High Fe’ periods.
Pyrosequencing analysis indicated a complete reorganiza-
tion of the gut microbiota composition during fermentation
periods in which Fe was chelated by 2,2′-dipyridyl
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(reactor 1) or Chelex® (reactor 2). The addition of
2,2′-dipyridyl in reactor 1 lead to a strong decrease in the
most abundant families Lachnospiracea (Roseburia spp.,
Dorea spp., Blautia spp.) from 79.4% (‘No Fe’, period 6,
reactor 1) to 4.5%, Bacteroidaceae from 3.4% to 0.2%,
and Ruminococcacae from 4.8% to 0.2% (Fig. 2a, Table
S1). Simultaneously, a strong increase in previously sub-
dominant families like Bifidobacteriaceae, Lactobacillaceae,
Enterobacteriaceae, and Enterococcaceae was observed.
Moreover, the addition of 2,2-dipyridyl decreased the
number of unclassified reads on family level (Fig. 2a) as
well as on genus level (Fig. 2b, Table S3).
The treatment of the fermentation medium with
Chelex® (reactor 2) also decreased the families Bacteroida-
ceae from 3.87% to 1.39% and Ruminococcaceae from
2.73% to 0.26% but had no impact on total Lachnospira-
ceae (Fig. 3a, Table S2). On the genus level, however, a
moderate decrease in the Lachnospiraceae members Roseb-
uria spp. (6.10 to 3.98%) and Dorea spp. (2.98 to 1.35%)
was observed compared with the previous ‘No Fe’ period
(Fig. 3b, Table S4). In addition, an increase in Bifidobacte-
riaceae, Lactobacillaceae, and Enterobacteriaceae was
observed.
Metabolite analysis
SCFA, isoacids, as well as lactate and formate, were deter-
mined daily in fermentation effluents by HPLC and were
used as markers of system stability (Fig. 4, Table 3). Dur-
ing all three fermentations inoculated with different mic-
robiota, acetate was the main metabolite followed by
either butyrate (fermentation 1) or propionate (fermenta-
tions 2 and 3).
Metabolites concentrations of the SCFA acetate, buty-
rate, and propionate in reactor 1 are depicted in Fig. 4 for
each day during fermentation 1. Stability was usually
reached 6 days after the switch to a medium with a differ-
ent Fe concentration following a transition period. The
‘No Fe’ periods in fermentation 1 showed reproducible
effects on the metabolic activity of the gut microbiota.
Acetate concentrations decreased significantly in fermenta-
tion effluents under ‘No Fe’ conditions (reactor 1: period
3, 12%; period 6, 30%; reactor 2: period 6, 18%)
compared with previous ‘Normal Fe’ or ‘High Fe’ periods
(Table 3, Fig. 4). However, butyrate concentrations
remained stable and were unaffected by the switch to ‘No
Fe’ medium. A 1 : 1 ratio of acetate/butyrate was measured
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Fig. 2. Microbial composition in effluents of reactor 1 in fermentation 1. Percentages of the most abundant families (a) and genera (b) identified
by pyrosequencing of the V5–V6 hypervariable regions of the 16S rRNA gene.
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during ‘No Fe’ periods, while in ‘Normal Fe’ periods, this
ratio was 2 : 1. Moreover, isobutyrate and isovalerate con-
centrations were decreased, while formate accumulated in
the fermentation effluents during ‘No Fe’ periods.
‘High Fe’ fermentation conditions applied after ‘No Fe’
period (reactor 1, fermentation 1) restored the acetate
concentration to 63.4 ± 5.3 mM and significantly
increased isobutyrate and isovalerate concentrations to
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Fig. 3. Microbial composition in effluents of reactor 2 in fermentation 1. Percentages of the most abundant families (a) and genera (b) identified
by pyrosequencing of the V5–V6 hypervariable regions of the 16S rRNA gene.
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concentrations measured during ‘Normal Fe’ period
(Table 3, Fig. 4). Butyrate production remained stable
also during very high Fe concentrations.
The metabolic activity of the gut microbiota was
strongly impacted during very low Fe conditions with
2,2′-dipyridyl. In reactor 1 of fermentation 1 (period 7),
butyrate (84%) and propionate (55%) production
were significantly decreased, while acetate concentrations
strongly increased compared with the previous fermenta-
tion period (Table 3, Fig. 4). Moreover, intermediate
products lactate and formate, which were not detected in
the preceding period, were present at high concentrations
during very low Fe availability, reaching 14.7 ± 2.9 and
22.1 ± 1.0 mM, respectively.
During very low Fe fermentation conditions obtained
by chelating Fe with Chelex® (fermentation 1, reactor 2,
period 7), similar but less pronounced effects on the gut
microbiota metabolic activity were observed than with
2,2′-dipyridyl (Table 3). Butyrate concentrations were sig-
nificantly reduced while lactate and formate accumulated
in the effluent.
The effects of 2,2′-dipyridyl were confirmed during
fermentations 2 and 3 with different microbiotas (Fig. 5a
and b). Butyrate concentration was reduced significantly
by 55% in the Fe-deficient reactors (17.1 ± 2.6 and
14.8 ± 3.0 mM, for fermentations 2 and 3, respectively)
compared with the control reactors (38.2 ± 2.6 and
33.5 ± 4.6 mM). In contrast to fermentation 1, no
increase in acetate concentration was recorded in the test
reactors. However, the ratios of acetate/propionate/buty-
rate show a higher acetate portion in the Fe-deficient
Table 3. Concentration of metabolites (mM) measured by HPLC in effluent samples of treatment periods in reactors 1 and 2 of fermentation 1
Acetate Butyrate Propionate Isobutyrate Isovalerate Lactate Formate
Reactor 1
Normal Fe 69.6 ± 4.4 44.2 ± 3.0 8.2 ± 1.0 7.3 ± 1.0 5.0 ± 0.5 n.d. n.d.
Low Fe 56.4 ± 2.0* 44.5 ± 1.3 11.1 ± 0.3* 3.4 ± 2.1* 3.6 ± 0.3* n.d. n.d.
No Fe 49.6 ± 2.1* 49.3 ± 2.9 * 9.9 ± 0.1* 1.8 ± 3.0 2.0 ± 0.8* n.d. 9.7 ± 0.8
High Fe 63.4 ± 5.3* 49.0 ± 0.9 7.5 ± 0.2* 7.4 ± 0.6* 5.6 ± 0.2* 1.2 ± 1.4 n.d.
High Fe 61.7 ± 3.5 50.7 ± 1.9 9.7 ± 0.6* 9.8 ± 0.3* 5.6 ± 1.1 n.d. n.d.
No Fe 43.1 ± 2.4* 48.1 ± 2.8 8.9 ± 1.1 4.6 ± 0.7* 1.3 ± 0.1* n.d. n.d.
2′2-Dip 72.4 ± 4.9* 7.5 ± 2.3* 4.0 ± 0.7* 6.1 ± 0.8 n.d. 14.7 ± 2.9 22.1 ± 1.0
Reactor 2
Normal Fe 96.1 ± 28.2 40.4 ± 11.2 16.6 ± 4.1 10.7 ± 3.2 5.9 ± 1.5 n.d. n.d.
High Fe 95.6 ± 16.4 42.6 ± 4.1 13.5 ± 2.4 8.4 ± 3.7 7.2 ± 1.2 n.d. n.d.
High Fe 88.1 ± 2.3 39.3 ± 3.9 11.7 ± 0.5 6.9 ± 5.1 6.4 ± 0.3 n.d. n.d.
Normal Fe 89.3 ± 3.1 30.3 ± 1.5* 9.2 ± 0.0* 10.9 ± 0.7 5.4 ± 0.1* 3.2 ± 0.6 n.d.
Normal Fe 62.9 ± 0.9* 44.4 ± 0.8* 9.6 ± 0.6 9.0 ± 0.8* 4.6 ± 0.0* n.d. n.d.
No Fe 51.5 ± 2.5* 42.4 ± 1.4 7.5 ± 0.2* 6.6 ± 0.4* 2.9 ± 0.2* n.d. 0.5 ± 0.8
Chelex 43.1 ± 1.1* 25.6 ± 1.6* 5.6 ± 1.7 2.0 ± 1.8* 0.5 ± 0.2* 2.5 ± 1.1 1.0 ± 1.8
Data are means ± SD of the last 3 days of each fermentation period; samples were analyzed in duplicate. Means with an asterisk (*) differ signifi-
cantly from the previous treatment period within the same metabolite, P < 0.05.
n.d., not detected.
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Fig. 5. Metabolite concentrations in effluents of the control reactor
and Fe-deficient reactor (addition of 2,2′-dipyridyl) during
fermentation 2 (a) and fermentation 3 (b) measured by HPLC. Data
points are means ± SD of the last three fermentation days. Columns
with an asterisk (*) are significantly different from the control reactor
within the same metabolite, P < 0.05.
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reactors of fermentations 2 and 3 (67 : 20 : 13; 59 :
29 : 12, respectively) compared with control reactors
(60 : 19 : 21; 49 : 31 : 20, respectively).
Salmonella infection simulation
Growth of S. Typhimurium N-15 during ‘High Fe’ (period
5) in reactor 1, fermentation 1, was slower compared with
‘Normal Fe’ (period 5) in reactor 2 resulting in a signifi-
cantly lower S. Typhimurium N-15 count during the last
3 days in reactor 1 compared with reactor 2 (5.0 ± 0.2
and 6.2 ± 0.5 log CFU mL1, respectively). During the
next ‘No Fe’ periods (period 6), S. Typhimurium N-15
reached similar counts in reactors 1 and 2 (7.0 ± 0.2 and
7.2 ± 0.1 log CFU mL1, respectively) (Table 2).
Discussion
Our results highlight the importance of Fe for the gut
microbiota composition and metabolic activity during
in vitro colonic fermentation. Especially, Fe-deficient con-
ditions (‘No Fe’ fermentation conditions, 2,2′-dipyridyl-
and Chelex®-treated medium) modulated the metabolite
concentrations in the fermentation effluent and the gut
microbiota composition.
During fermentation periods mimicking Fe deficiency,
a significant decrease in acetate was observed in all three
fermentations. Acetate is produced by nearly all gut
bacteria either by the regular glycolytic pathway via pyru-
vate (Macfarlane & Macfarlane, 2003) or by the reductive
acetyl-CoA pathway, which uses CO2 and H2 (Miller &
Wolin, 1996; Leclerc et al., 1997). The latter pathway
involves several Fe-dependent enzymes and can account
for 35% of the total acetate (Rey et al., 2010). Therefore,
Fe-restricted conditions could inhibit the conversion of
CO2 and H2 to acetate resulting in a decrease in acetate
production. Moreover, bacteria possessing the reductive
acetyl-CoA pathway often co-metabolize formate (Wolin
& Miller, 1993; Rey et al., 2010). Indeed, during Fe-
deficient conditions, an accumulation of formate was
observed. The bacteria using the reductive acetyl-CoA
pathway belong to many different genera, which may
explain that no decrease in bacterial numbers was
detected by qPCR primers targeting large bacterial
groups. However, pyrosequencing analysis of the entire
16S rRNA gene pool revealed a decrease in the genus
Blautia during very low Fe availability (2,2′-dipyridyl).
Some species of this genus possess the reductive acetyl-CoA
pathway (Liu et al., 2008; Rey et al., 2010). Moreover,
during ‘No Fe’ fermentation conditions (1.56 ± 0.1
mg Fe L1), isobutyrate and isovalerate concentrations in
fermentation effluents were reduced, suggesting a decrease
in protein fermentation (Hoyles & Wallace, 2010).
On the other hand, bacterial composition was only
marginally affected by ‘No Fe’ fermentation conditions,
indicating that Fe levels of 1.56 ± 0.1 mg Fe L1 mainly
affect the metabolic activity of the gut microbiota. How-
ever, an increase in Ruminococcus spp. and a decrease in
F. prausnitzii were observed in reactor 1 of fermentation
1 during ‘No Fe’ conditions, which can explain the stable
Clostridium Cluster IV numbers.
When very low Fe conditions were generated by either
adding 2,2′-dipyridyl or treating the fermentation medium
with Chelex® (0.9 ± 0.2 mg Fe L1), a large perturbation
of the gut microbiota bacterial composition as well as
metabolism was observed. Butyrate was the most affected
metabolite with a decrease of up to 84% in correlation
with a strong decrease in 16S rRNA gene copy numbers of
the butyrate producers Roseburia spp./E. rectale. These
data were confirmed by pyrosequencing, indicating a lower
abundance of Roseburia spp. during very low Fe fermenta-
tion conditions (2,2′-dipyridyl, Chelex®). Butyrate-pro-
ducing bacteria and butyrate production were strongly
impacted by Fe deficiency most likely due to the need of
Fe as a cofactor in hydrogenases and oxidoreductases pres-
ent in the butyrate production pathway (Falony et al.,
2009). Some butyrate-producing bacteria such as F. pra-
usnitzii can convert acetate to butyrate (Pryde et al.,
2002), which could explain the accumulation of acetate
when butyrate production was impaired. They can also
produce lactate from pyruvate especially when the pyru-
vate–butyrate pathway is blocked because of the lack of Fe
needed for the activity of hydrogenases and oxidoreducta-
ses (De Vuyst & Leroy, 2011) as observed in this study
during very low Fe fermentation conditions (Table 3).
Moreover, propionate concentrations were decreased in
fermentation effluents along with a decrease in the propio-
nate producer Bacteroides spp. 16S rRNA gene copy num-
bers during very low Fe concentrations.
The strong decrease in butyrate producers, Ruminococ-
cus spp. and Bacteroides spp., can open a niche for the
growth of bacteria better adapted to low Fe environ-
ments. Enterobacteriaceae and Lactobacillus/Leuconostoc/
Pediococcus spp. significantly increased during the last two
fermentation periods (‘No Fe’ and 2,2′-dipyridyl or Che-
lex®) in reactors 1 and 2 during fermentation 1 (Table 2,
Figs 2a, b and 3a, b). Enterobacteriaceae are very good Fe
scavengers (Andrews et al., 2003), and lactobacilli do not
require Fe for growth in nucleotide-rich environments
(Imbert & Blondeau, 1998; Elli et al., 2000), which gives
both bacterial groups a growth advantage during
Fe-restricted conditions. Bifidobacteria are reported to
bind Fe to their cell walls and membranes, which may
increase their survival during low Fe environmental con-
ditions (Kot & Bezkorovainy, 1999). The clear growth
advantage of bifidobacteria in a complex gut microbiota
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during very low Fe conditions is demonstrated by their
high abundance (64.8%) during the 2,2′-dipyridyl and
Chelex® fermentation period.
Fe supplementation after low Fe conditions restored
acetate, isobutyrate, and isovalerate concentrations, indi-
cating again the dependence of the reductive acetyl-CoA
pathway and protein fermentation pathways on Fe.
Moreover, Clostridium Clust IV members, such as
F. prausnitzii, were promoted because of Fe supplementa-
tion after Fe deficiency.
The findings of this in vitro fermentation studies are
very consistent with the data of a recent rat study using an
Fe depletion–repletion assay to investigate the impact of
Fe on gut microbiota (Dostal et al., 2012). Similar to our
in vitro results, Fe deficiency in rats induced a strong
decrease in butyrate and propionate production along
with a decrease in butyrate- and propionate-producing
bacteria. Fe supplementation also restored metabolic activ-
ity of the gut microbiota. An increase in lactobacilli during
Fe deficiency was observed in this rat study similar to the
present study, which is in agreement with the mice study
of Tompkins et al. (2001). In contrast, a human study car-
ried out in India observed a decrease in the L. acidophilus
group in Fe-deficient women (Balamurugan et al., 2010),
indicating that also other mechanisms such as bacterial
population dynamics impact this bacterial group.
In Fe-deficient rats (Dostal et al., 2012) and in this
in vitro study, Enterobacteriaceae increased under low
Fe conditions. In a nutritional trial in Coˆte d’Ivoire
(Zimmermann et al., 2010), where children were given an
Fe-fortified diet over 6 months, and in a study with
weanling pigs (Lee et al., 2008), Fe fortification increased
Enterobacteriaceae. These contradictory results suggest
that changes in Enterobacteriaceae numbers might not
only be due to Fe concentration in the gut lumen but
also react to host responses to Fe and other environmen-
tal factors. For example, in the Coˆte d’Ivoire study
(Zimmermann et al., 2010), calprotectin, a marker for
intestinal inflammation, was increased in Fe-fortified chil-
dren, and mucosal inflammation can give Enterobacteriaceae
a growth advantage (Winter et al., 2010). In in vitro
fermentations, environmental and host factors are
excluded. Thus, the lack of host inflammation factors
might also be the explanation for the slower growth perfor-
mance of S. Typhimurium N-15 in ‘High Fe’ conditions
compared with ‘Normal Fe’ conditions in this in vitro
study. However, it needs to be considered that virulence
factors were not investigated in the present in vitro fermen-
tation study, and although growth of S. Typhimurium
N-15 was impaired because of high amounts of Fe, virulence
might be promoted, and further investigations are needed.
Overall, our data suggest that ‘No Fe’ and very low Fe
fermentation conditions could lead to negative impacts
on gut health. Especially, gut microbiota metabolites
influence gut health to a large extent. During Fe-restricted
fermentation conditions, a significant decrease in the ben-
eficial metabolites acetate, butyrate, and propionate was
observed. Acetate is mainly used as energy source in col-
onocytes (Hoyles & Wallace, 2010), and a recent study
suggested that the protection from enteropathogenic
infection by bifidobacteria is partially attributed to the
production of acetate (Fukuda et al., 2011). The impact
of butyrate on gut health has been studied extensively
and has been attributed to anti-inflammatory properties,
anticancerogenic effects, and regulatory functions in cell
proliferation, and butyrate can act as an energy source for
intestinal cells (Luhrs et al., 2002; Hamer et al., 2008,
2009; Louis & Flint, 2009). Propionate is involved in cho-
lesterol- and lipid-lowering mechanisms (Delzenne &
Williams, 2002). However, not all metabolites have bene-
ficial effects on gut health. The accumulation of lactate in
feces has been correlated with inflammatory bowel disease
and ulcerative colitis (Vernia et al., 1988; Hove et al.,
1994), and lactate concentrations increased during low Fe
availability during fermentation 1. Moreover, the strong
decrease in dominant bacterial groups such as Roseburia
spp./E. rectale, Clostridium Cluster IV, and Bacteroides
spp. because of low Fe could open nutrient and growth
niches for environmental bacteria.
In the present study, we demonstrated that the gut
microbiota composition as well as the metabolic activity
is strongly impacted by Fe availability in vitro, and espe-
cially, very low Fe fermentation conditions induced gut
microbiota changes that might have negative effects on
gut health. However, the underlying mechanisms of the
importance of Fe for the gut microbiota need to be fur-
ther investigated and elucidated.
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